These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 10952317)

  • 41. Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.
    Wang S; Fan W; Wan B; Tu M; Jin F; Liu F; Xu H; Han P
    PLoS One; 2017; 12(2):e0172498. PubMed ID: 28225791
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study.
    Kadkol SS; Lin AY; Barak V; Kalickman I; Leach L; Valyi-Nagy K; Majumdar D; Setty S; Maniotis AJ; Folberg R; Pe'er J
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):802-6. PubMed ID: 16505010
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunophenotypic differences between uveal and cutaneous melanomas.
    Iwamoto S; Burrows RC; Kalina RE; George D; Boehm M; Bothwell MA; Schmidt R
    Arch Ophthalmol; 2002 Apr; 120(4):466-70. PubMed ID: 11934320
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Canine Melanomas as Models for Human Melanomas: Clinical, Histological, and Genetic Comparison.
    Prouteau A; André C
    Genes (Basel); 2019 Jun; 10(7):. PubMed ID: 31262050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The histopathology of cutaneous malignant melanoma.
    Barnhill RL; Mihm MC
    Semin Diagn Pathol; 1993 Feb; 10(1):47-75. PubMed ID: 8506417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PUMA expression is significantly reduced in human cutaneous melanomas.
    Karst AM; Dai DL; Martinka M; Li G
    Oncogene; 2005 Feb; 24(6):1111-6. PubMed ID: 15690057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene expression profiling in uveal melanoma: technical reliability and correlation of molecular class with pathologic characteristics.
    Plasseraud KM; Wilkinson JK; Oelschlager KM; Poteet TM; Cook RW; Stone JF; Monzon FA
    Diagn Pathol; 2017 Aug; 12(1):59. PubMed ID: 28778171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Uveal melanoma: the good and the bad.
    Hadden PW
    Clin Exp Ophthalmol; 2008 Apr; 36(3):203. PubMed ID: 18412585
    [No Abstract]   [Full Text] [Related]  

  • 49. [But...was there ever a Clark classification of melanomas?].
    Sánchez Yus E; Herrera M; Simón RS; Requena L
    Actas Dermosifiliogr; 2010; 101(1):19-30. PubMed ID: 20109389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reduced expression of autotaxin predicts survival in uveal melanoma.
    Singh AD; Sisley K; Xu Y; Li J; Faber P; Plummer SJ; Mudhar HS; Rennie IG; Kessler PM; Casey G; Williams BG
    Br J Ophthalmol; 2007 Oct; 91(10):1385-92. PubMed ID: 17475713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of SDHD promoter mutations in various types of melanoma.
    Scholz SL; Horn S; Murali R; Möller I; Sucker A; Sondermann W; Stiller M; Schilling B; Livingstone E; Zimmer L; Reis H; Metz CH; Zeschnigk M; Paschen A; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
    Oncotarget; 2015 Sep; 6(28):25868-82. PubMed ID: 26327518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association between traditional clinical high-risk features and gene expression profile classification in uveal melanoma.
    Nguyen BT; Kim RS; Bretana ME; Kegley E; Schefler AC
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):421-427. PubMed ID: 29185101
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cutaneous malignant melanoma: classification and clinical diagnosis.
    Porras BH; Cockerell CJ
    Semin Cutan Med Surg; 1997 Jun; 16(2):88-96. PubMed ID: 9220547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
    Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
    Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular determinants of human uveal melanoma invasion and metastasis.
    Seftor EA; Meltzer PS; Kirschmann DA; Pe'er J; Maniotis AJ; Trent JM; Folberg R; Hendrix MJ
    Clin Exp Metastasis; 2002; 19(3):233-46. PubMed ID: 12067204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.
    Maniotis AJ; Folberg R; Hess A; Seftor EA; Gardner LM; Pe'er J; Trent JM; Meltzer PS; Hendrix MJ
    Am J Pathol; 1999 Sep; 155(3):739-52. PubMed ID: 10487832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular markers in melanoma.
    Kashani-Sabet M
    Br J Dermatol; 2014 Jan; 170(1):31-5. PubMed ID: 23815339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Histological classification and assessment of malignant melanomas].
    Hornstein OP
    Haematol Blood Transfus; 1978; 21():249-75. PubMed ID: 738637
    [No Abstract]   [Full Text] [Related]  

  • 59. Genomic investigations of posterior uveal melanoma.
    Hovland PG; Trempe C
    Semin Ophthalmol; 2005; 20(4):231-8. PubMed ID: 16352494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Infrequent expression of the MAGE gene family in uveal melanomas.
    Mulcahy KA; Rimoldi D; Brasseur F; Rodgers S; Liénard D; Marchand M; Rennie IG; Murray AK; McIntyre CA; Platts KE; Leyvraz S; Boon T; Rees RC
    Int J Cancer; 1996 Jun; 66(6):738-42. PubMed ID: 8647642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.